PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NVAX vs. OCGN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


NVAXOCGN
YTD Return168.75%240.87%
1Y Return68.85%182.83%
3Y Return (Ann)-53.95%-39.31%
5Y Return (Ann)16.98%-28.49%
Sharpe Ratio0.431.65
Daily Std Dev136.72%101.16%
Max Drawdown-98.82%-99.97%
Current Drawdown-95.97%-99.72%

Fundamentals


NVAXOCGN
Market Cap$1.25B$409.15M
EPS-$5.41-$0.26
PEG Ratio0.000.00
Revenue (TTM)$983.71M$6.04M
Gross Profit (TTM)-$156.05M-$49.76M
EBITDA (TTM)-$510.99M-$64.83M

Correlation

-0.50.00.51.00.2

The correlation between NVAX and OCGN is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

NVAX vs. OCGN - Performance Comparison

In the year-to-date period, NVAX achieves a 168.75% return, which is significantly lower than OCGN's 240.87% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%-98.00%-96.00%-94.00%-92.00%-90.00%-88.00%December2024FebruaryMarchAprilMay
-88.10%
-99.72%
NVAX
OCGN

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Novavax, Inc.

Ocugen, Inc.

Risk-Adjusted Performance

NVAX vs. OCGN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novavax, Inc. (NVAX) and Ocugen, Inc. (OCGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NVAX
Sharpe ratio
The chart of Sharpe ratio for NVAX, currently valued at 0.43, compared to the broader market-2.00-1.000.001.002.003.004.000.43
Sortino ratio
The chart of Sortino ratio for NVAX, currently valued at 2.21, compared to the broader market-4.00-2.000.002.004.006.002.21
Omega ratio
The chart of Omega ratio for NVAX, currently valued at 1.25, compared to the broader market0.501.001.502.001.25
Calmar ratio
The chart of Calmar ratio for NVAX, currently valued at 0.60, compared to the broader market0.002.004.006.000.60
Martin ratio
The chart of Martin ratio for NVAX, currently valued at 1.54, compared to the broader market-10.000.0010.0020.0030.001.54
OCGN
Sharpe ratio
The chart of Sharpe ratio for OCGN, currently valued at 1.65, compared to the broader market-2.00-1.000.001.002.003.004.001.65
Sortino ratio
The chart of Sortino ratio for OCGN, currently valued at 2.44, compared to the broader market-4.00-2.000.002.004.006.002.44
Omega ratio
The chart of Omega ratio for OCGN, currently valued at 1.33, compared to the broader market0.501.001.502.001.33
Calmar ratio
The chart of Calmar ratio for OCGN, currently valued at 1.67, compared to the broader market0.002.004.006.001.67
Martin ratio
The chart of Martin ratio for OCGN, currently valued at 5.27, compared to the broader market-10.000.0010.0020.0030.005.27

NVAX vs. OCGN - Sharpe Ratio Comparison

The current NVAX Sharpe Ratio is 0.43, which is lower than the OCGN Sharpe Ratio of 1.65. The chart below compares the 12-month rolling Sharpe Ratio of NVAX and OCGN.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50December2024FebruaryMarchAprilMay
0.43
1.65
NVAX
OCGN

Dividends

NVAX vs. OCGN - Dividend Comparison

Neither NVAX nor OCGN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NVAX vs. OCGN - Drawdown Comparison

The maximum NVAX drawdown since its inception was -98.82%, roughly equal to the maximum OCGN drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for NVAX and OCGN. For additional features, visit the drawdowns tool.


-100.00%-99.00%-98.00%-97.00%-96.00%December2024FebruaryMarchAprilMay
-95.97%
-99.72%
NVAX
OCGN

Volatility

NVAX vs. OCGN - Volatility Comparison

Novavax, Inc. (NVAX) has a higher volatility of 78.02% compared to Ocugen, Inc. (OCGN) at 38.26%. This indicates that NVAX's price experiences larger fluctuations and is considered to be riskier than OCGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%December2024FebruaryMarchAprilMay
78.02%
38.26%
NVAX
OCGN

Financials

NVAX vs. OCGN - Financials Comparison

This section allows you to compare key financial metrics between Novavax, Inc. and Ocugen, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items